Wed, 16 Oct 2024
Headlines:
No Ads
WHO approves first mpox vaccine for global use
Published on: Saturday, September 14, 2024
Published on: Sat, Sep 14, 2024
By: Bernama, Xinhua
Text Size:
Share this story
WHO approves first mpox vaccine for global use
An undated colorised transmission electron micrograph of mpox virus particles (pink) found within an infected cell (yellow), cultured in the laboratory, captured at the National Institute of Allergy and Infectious Diseases (NIAID) Integrated Research Facility (IRF) in Fort Detrick, Maryland. — Reuters pic
GENEVA: The World Health Organisation (WHO) announced yesterday the approval of the MVA-BN vaccine, developed by Bavarian Nordic A/S, as the first-ever mpox vaccine to be added to its prequalification list, reported Xinhua.

This pre-qualification approval is expected to greatly improve access to the vaccine in regions facing urgent outbreaks, especially in Africa, aiding efforts to reduce transmission and control the spread of the disease.

Advertisement
“This first pre-qualification of a vaccine against mpox is an important step in our fight against the disease, both in the context of the current outbreaks in Africa, and in the future,” WHO Director-General Tedros Adhanom Ghebreyesus said.

He stressed the need to scale up vaccine procurement and distribution to ensure equitable access for those most at risk.

SPONSORED CONTENT
Enjoy a taste of Malaysia, everyday with Ayam Brand™  local pastes
Enjoy a taste of Malaysia, everyday with Ayam Brand™ local pastes
SHAH ALAM: Fact: Every time Malaysians travel abroad, we almost immediately miss the taste of home. You don’t need to be homesick to celebrate Malaysia’s rich culinary heritage when you can savor the authentic taste of Malaysia in your own home with Ayam Brand™  cooking pastes.
The vaccine is administered in two doses, four weeks apart, for adults aged 18 and over.

The pre-qualification decision will accelerate procurement by international agencies and speed up national regulatory approvals, according to WHO Assistant Director-General Yukiko Nakatani.

Advertisement
Current data indicate that the vaccine is 76 per cent effective after a single dose and 82 per cent effective after two doses. WHO emphasised the need for continued data collection on the vaccine’s safety and effectiveness.
* Follow us on Instagram and join our Telegram and/or WhatsApp channel(s) for the latest news you don't want to miss.

* Do you have access to the Daily Express e-paper and online exclusive news? Check out subscription plans available.
Advertisement
Share this story
Advertisement
Advertisement
Follow Us  
Follow us              
Daily Express TV  
© Copyright 2024 Sabah Publishing House Sdn. Bhd. (Co. No. 35782-P)
close
Try 1 month for RM 18.00
Already a subscriber? Login here
Try 1 month for RM 18.00
open
Try 1 month for RM 18.00
Already a subscriber? Login here